Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

VIR holding history

Vir Biotechnology, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VIR overviewAll 13F holders of VIRFull Q2 2026 holdings

Shares (Q2 2026)
416,403
Value
$4.24M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VIR by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026416,403$4.24M<0.1%−401,282−49.1%ReducedHolders
Q1 2026817,685$7.33M<0.1%+767,893+1,542.2%AddedHolders
Q4 202549,792$300.2K<0.1%+16,268+48.5%AddedHolders
Q3 202533,524$191.4K<0.1%−2,733−7.5%ReducedHolders
Q2 202536,257$182.7K<0.1%−470,447−92.8%ReducedHolders
Q1 2025506,704$3.28M<0.1%+4,704+0.9%AddedHolders
Q4 2024502,000$3.68M<0.1%−428,655−46.1%ReducedHolders
Q3 2024930,655$6.97M<0.1%+8,101+0.9%AddedHolders
Q2 2024922,554$8.21M<0.1%+276,300+42.8%AddedHolders
Q1 2024646,254$6.55M<0.1%−122,890−16.0%ReducedHolders
Q4 2023769,144$7.74M<0.1%−111,087−12.6%ReducedHolders
Q3 2023880,231$8.25M<0.1%+826,696+1,544.2%AddedHolders
Q2 202353,535$1.31M<0.1%−13,765−20.5%ReducedHolders
Q1 202367,300$1.57M<0.1%+22,305+49.6%AddedHolders
Q4 202244,995$1.14M<0.1%+30,177+203.7%AddedHolders
Q3 202214,818$286.0K<0.1%+6,230+72.5%AddedHolders
Q2 20228,588$219.0K<0.1%−43,642−83.6%ReducedHolders
Q1 202252,230$1.34M<0.1%−92,572−63.9%ReducedHolders
Q4 2021144,802$6.06M<0.1%−22,324−13.4%ReducedHolders
Q3 2021167,126$7.27M<0.1%−52,102−23.8%ReducedHolders
Q2 2021219,228$10.4M<0.1%+102,936+88.5%AddedHolders
Q1 2021116,292$5.96M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.